-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Evolent Health, Lowers Price Target to $6

Benzinga·02/26/2026 13:53:58
Listen to the news
Truist Securities analyst Jailendra Singh maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price target from $10 to $6.